Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |